Literature DB >> 30581078

Constructing and Deconstructing Cancers using Human Pluripotent Stem Cells and Organoids.

Ryan C Smith1, Viviane Tabar2.   

Abstract

Cell lines and animal models have provided the foundation of cancer research for many years. However, human pluripotent stem cells (hPSCs) and organoids are increasingly enabling insights into tumor development, progression, and treatment. Here, we review recent studies using hPSCs to elucidate the reciprocal roles played by genetic alterations and cell identity in cancer formation. We also review studies using human organoids as models that recapitulate both intra- and inter-tumoral heterogeneity to gain new insights into tumorigenesis and treatment responses. Finally, we highlight potential opportunities for cancer research using hPSC-derived organoids and genome editing in the future.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cancer; cell identity; cell-of-origin; differentiation; disease modeling; drug screening; genome editing; organoids; pluripotent stem cells; tumor heterogeneity

Mesh:

Year:  2018        PMID: 30581078      PMCID: PMC6516073          DOI: 10.1016/j.stem.2018.11.012

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  106 in total

1.  Stage-Specific Human Induced Pluripotent Stem Cells Map the Progression of Myeloid Transformation to Transplantable Leukemia.

Authors:  Andriana G Kotini; Chan-Jung Chang; Arthur Chow; Han Yuan; Tzu-Chieh Ho; Tiansu Wang; Shailee Vora; Alexander Solovyov; Chrystel Husser; Malgorzata Olszewska; Julie Teruya-Feldstein; Deepak Perumal; Virginia M Klimek; Alexandros Spyridonidis; Raajit K Rampal; Lewis Silverman; E Premkumar Reddy; Elli Papaemmanuil; Samir Parekh; Benjamin D Greenbaum; Christina S Leslie; Michael G Kharas; Eirini P Papapetrou
Journal:  Cell Stem Cell       Date:  2017-02-16       Impact factor: 24.633

2.  Tight Junction Protein Claudin-2 Promotes Self-Renewal of Human Colorectal Cancer Stem-like Cells.

Authors:  Sophie Paquet-Fifield; Shir Lin Koh; Lesley Cheng; Laura M Beyit; Carolyn Shembrey; Christina Mølck; Corina Behrenbruch; Marina Papin; Meritxell Gironella; Sophie Guelfi; Ramona Nasr; Fanny Grillet; Michel Prudhomme; Jean-Francois Bourgaux; Antoni Castells; Jean-Marc Pascussi; Alexander G Heriot; Alain Puisieux; Melissa J Davis; Julie Pannequin; Andrew F Hill; Erica K Sloan; Frédéric Hollande
Journal:  Cancer Res       Date:  2018-03-06       Impact factor: 12.701

Review 3.  Cellular Pliancy and the Multistep Process of Tumorigenesis.

Authors:  Alain Puisieux; Roxane M Pommier; Anne-Pierre Morel; Fabrice Lavial
Journal:  Cancer Cell       Date:  2018-02-12       Impact factor: 31.743

4.  A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity.

Authors:  Norman Sachs; Joep de Ligt; Oded Kopper; Ewa Gogola; Gergana Bounova; Fleur Weeber; Anjali Vanita Balgobind; Karin Wind; Ana Gracanin; Harry Begthel; Jeroen Korving; Ruben van Boxtel; Alexandra Alves Duarte; Daphne Lelieveld; Arne van Hoeck; Robert Frans Ernst; Francis Blokzijl; Isaac Johannes Nijman; Marlous Hoogstraat; Marieke van de Ven; David Anthony Egan; Vittoria Zinzalla; Jurgen Moll; Sylvia Fernandez Boj; Emile Eugene Voest; Lodewyk Wessels; Paul Joannes van Diest; Sven Rottenberg; Robert Gerhardus Jacob Vries; Edwin Cuppen; Hans Clevers
Journal:  Cell       Date:  2017-12-07       Impact factor: 41.582

5.  Modeling familial cancer with induced pluripotent stem cells.

Authors:  Dung-Fang Lee; Jie Su; Huen Suk Kim; Betty Chang; Dmitri Papatsenko; Ruiying Zhao; Ye Yuan; Julian Gingold; Weiya Xia; Henia Darr; Razmik Mirzayans; Mien-Chie Hung; Christoph Schaniel; Ihor R Lemischka
Journal:  Cell       Date:  2015-04-09       Impact factor: 41.582

6.  Epigenomic alterations define lethal CIMP-positive ependymomas of infancy.

Authors:  S C Mack; H Witt; R M Piro; L Gu; S Zuyderduyn; A M Stütz; X Wang; M Gallo; L Garzia; K Zayne; X Zhang; V Ramaswamy; N Jäger; D T W Jones; M Sill; T J Pugh; M Ryzhova; K M Wani; D J H Shih; R Head; M Remke; S D Bailey; T Zichner; C C Faria; M Barszczyk; S Stark; H Seker-Cin; S Hutter; P Johann; S Bender; V Hovestadt; T Tzaridis; A M Dubuc; P A Northcott; J Peacock; K C Bertrand; S Agnihotri; F M G Cavalli; I Clarke; K Nethery-Brokx; C L Creasy; S K Verma; J Koster; X Wu; Y Yao; T Milde; P Sin-Chan; J Zuccaro; L Lau; S Pereira; P Castelo-Branco; M Hirst; M A Marra; S S Roberts; D Fults; L Massimi; Y J Cho; T Van Meter; W Grajkowska; B Lach; A E Kulozik; A von Deimling; O Witt; S W Scherer; X Fan; K M Muraszko; M Kool; S L Pomeroy; N Gupta; J Phillips; A Huang; U Tabori; C Hawkins; D Malkin; P N Kongkham; W A Weiss; N Jabado; J T Rutka; E Bouffet; J O Korbel; M Lupien; K D Aldape; G D Bader; R Eils; P Lichter; P B Dirks; S M Pfister; A Korshunov; M D Taylor
Journal:  Nature       Date:  2014-02-19       Impact factor: 49.962

7.  Organoid cultures derived from patients with advanced prostate cancer.

Authors:  Dong Gao; Ian Vela; Andrea Sboner; Phillip J Iaquinta; Wouter R Karthaus; Anuradha Gopalan; Catherine Dowling; Jackline N Wanjala; Eva A Undvall; Vivek K Arora; John Wongvipat; Myriam Kossai; Sinan Ramazanoglu; Luendreo P Barboza; Wei Di; Zhen Cao; Qi Fan Zhang; Inna Sirota; Leili Ran; Theresa Y MacDonald; Himisha Beltran; Juan-Miguel Mosquera; Karim A Touijer; Peter T Scardino; Vincent P Laudone; Kristen R Curtis; Dana E Rathkopf; Michael J Morris; Daniel C Danila; Susan F Slovin; Stephen B Solomon; James A Eastham; Ping Chi; Brett Carver; Mark A Rubin; Howard I Scher; Hans Clevers; Charles L Sawyers; Yu Chen
Journal:  Cell       Date:  2014-09-04       Impact factor: 41.582

8.  Role of heterozygous APC mutation in niche succession and initiation of colorectal cancer--a computational study.

Authors:  Roschen Sasikumar; John Raji Rejitha; Ponthananiyil Kumaran Binumon; Muraleedharan Manoj
Journal:  PLoS One       Date:  2011-08-05       Impact factor: 3.240

9.  Functional analysis of a chromosomal deletion associated with myelodysplastic syndromes using isogenic human induced pluripotent stem cells.

Authors:  Andriana G Kotini; Chan-Jung Chang; Ibrahim Boussaad; Jeffrey J Delrow; Emily K Dolezal; Abhinav B Nagulapally; Fabiana Perna; Gregory A Fishbein; Virginia M Klimek; R David Hawkins; Danwei Huangfu; Charles E Murry; Timothy Graubert; Stephen D Nimer; Eirini P Papapetrou
Journal:  Nat Biotechnol       Date:  2015-03-23       Impact factor: 54.908

10.  SPOP mutation drives prostate neoplasia without stabilizing oncogenic transcription factor ERG.

Authors:  Jonathan Shoag; Deli Liu; Mirjam Blattner; Andrea Sboner; Kyung Park; Lesa Deonarine; Brian D Robinson; Juan Miguel Mosquera; Yu Chen; Mark A Rubin; Christopher E Barbieri
Journal:  J Clin Invest       Date:  2017-12-04       Impact factor: 14.808

View more
  20 in total

Review 1.  A connection in life and death: The BCL-2 family coordinates mitochondrial network dynamics and stem cell fate.

Authors:  Megan L Rasmussen; Vivian Gama
Journal:  Int Rev Cell Mol Biol       Date:  2020-01-27       Impact factor: 6.813

Review 2.  Developing Bottom-Up Induced Pluripotent Stem Cell Derived Solid Tumor Models Using Precision Genome Editing Technologies.

Authors:  Kelsie L Becklin; Garrett M Draper; Rebecca A Madden; Mitchell G Kluesner; Tomoyuki Koga; Miller Huang; William A Weiss; Logan G Spector; David A Largaespada; Branden S Moriarity; Beau R Webber
Journal:  CRISPR J       Date:  2022-08

Review 3.  Bioengineering Approaches for the Advanced Organoid Research.

Authors:  Sang Ah Yi; Yixiao Zhang; Christopher Rathnam; Thanapat Pongkulapa; Ki-Bum Lee
Journal:  Adv Mater       Date:  2021-09-24       Impact factor: 30.849

Review 4.  The promise of human organoids in the digestive system.

Authors:  Masaaki Funata; Yasunori Nio; Derek M Erion; Wendy L Thompson; Takanori Takebe
Journal:  Cell Death Differ       Date:  2020-11-17       Impact factor: 12.067

Review 5.  Prevention of tumor risk associated with the reprogramming of human pluripotent stem cells.

Authors:  Kenly Wuputra; Chia-Chen Ku; Deng-Chyang Wu; Ying-Chu Lin; Shigeo Saito; Kazunari K Yokoyama
Journal:  J Exp Clin Cancer Res       Date:  2020-06-03

6.  A Simple Three-Dimensional In Vitro Culture Mimicking the In Vivo-Like Cell Behavior of Bladder Patient-Derived Xenograft Models.

Authors:  Robson Amaral; Maike Zimmermann; Ai-Hong Ma; Hongyong Zhang; Kamilla Swiech; Chong-Xian Pan
Journal:  Cancers (Basel)       Date:  2020-05-21       Impact factor: 6.639

Review 7.  Applications of patient-derived tumor xenograft models and tumor organoids.

Authors:  Go J Yoshida
Journal:  J Hematol Oncol       Date:  2020-01-07       Impact factor: 17.388

8.  Modeling medulloblastoma in vivo and with human cerebellar organoids.

Authors:  Claudio Ballabio; Marica Anderle; Matteo Gianesello; Chiara Lago; Evelina Miele; Marina Cardano; Giuseppe Aiello; Silvano Piazza; Davide Caron; Francesca Gianno; Andrea Ciolfi; Lucia Pedace; Angela Mastronuzzi; Marco Tartaglia; Franco Locatelli; Elisabetta Ferretti; Felice Giangaspero; Luca Tiberi
Journal:  Nat Commun       Date:  2020-01-29       Impact factor: 14.919

Review 9.  Advances in stem cell research for the treatment of primary hypogonadism.

Authors:  Lu Li; Vassilios Papadopoulos
Journal:  Nat Rev Urol       Date:  2021-06-29       Impact factor: 14.432

Review 10.  Modeling neoplastic disease with spheroids and organoids.

Authors:  Michele Zanoni; Michela Cortesi; Alice Zamagni; Chiara Arienti; Sara Pignatta; Anna Tesei
Journal:  J Hematol Oncol       Date:  2020-07-16       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.